Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Phil Rivers Technology logo — company profile

Phil Rivers Technology

Founded 2015 Series A Total: $90.00M AI, Biopharma +2

General Information

Company Name Phil Rivers Technology
Founded Year 2015
Industries AI, Biopharma, Biotechnology +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Phil Rivers Technology. To contact Phil Rivers Technology, visit philrivers.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Phil Rivers Technology

Phil Rivers Technology is a biopharmaceutical and biotechnology company founded in 2015. The company's focus lies in the integration of biotechnology and information technology to drive medical innovation. Phil Rivers Technology's advanced digital twin technology stands as a key asset, enabling the systematic identification of oncology medication targets, precise forecasting of therapy responders, and accurate locational indications. The company recently secured a noteworthy CNY90.00M Series A investment on July 7, 2022, with Insight Capital as the lead investor. This funding underlines the confidence of investors in the company's vision and potential to make significant strides in the healthcare industry.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A CNY90.00M 1
Insight Capital
Insight Capital
07 Jul 2022

Phil Rivers Technology Alternatives & Competitors

View All Alternatives
Phil Rivers Technology vs
Tychon Biosciences
Tychon Biosciences

Advancing new therapies that direct the body how to fight and beat cancer.

Angel
1 employees
Biopharma, Biotechnology
Phil Rivers Technology vs
ABL Bio Inc.
ABL Bio Inc. Korea South

A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseas...

IPO
64 employees
Biotechnology, Health Care
Phil Rivers Technology vs
Kedalion Therapeutics
Kedalion Therapeutics

Experience precise, efficient, and comfortable ocular drug delivery with our innovative digital plat...

Series B
Biotechnology, Health Care
View all alternatives

FAQ About Phil Rivers Technology

Phil Rivers Technologies offers a platform for medical innovation by integrating biotechnology and information technology. Phil Rivers Technology’s advanced digital twin technology systematically identifies oncology medication targets, accurately locates applicable indications, and precisely foreca...
Phil Rivers Technology was founded in 2015.
Phil Rivers Technology operates in AI, Biopharma, Biotechnology and Health Care.
Phil Rivers Technology has completed 1 funding round, raising a total of $90.00M. The latest funding stage is Series A.
Top alternatives and competitors to Phil Rivers Technology include Tychon Biosciences, ABL Bio Inc., Kedalion Therapeutics, omnisense.ai, Baixinghua AI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phil Rivers Technology and Tychon Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phil Rivers Technology, https://bouncewatch.com/company/phil-rivers-technology, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes